CONTACT
CONTACT

NEWS

Credibility and confidence

November 8, 2024

Surgeons have completed more than 15,000 sleeve gastrectomy procedures using the Titan SGS™ Stapler.1

1.Data on file at Teleflex Incorporated.

New study reports perioperative outcomes of the Titan SGS™ Stapler

November 1, 2024

Here’s exciting news for patients and surgeons: a study published in Obesity Surgery in August 2024 links our Titan SGS™ Stapler to potentially enhanced perioperative outcomes compared to multi-fire surgical staplers.

Read More

START ACHIEVING REPEATABLE AND CONSISTENT OUTCOMES
AND REDUCE THE COST OF CARE

EXPERIENCE THE STANDARD SLEEVE PORTFOLIO OF SURGICAL SOLUTIONS

REQUEST TRAINING

START ACHIEVING REPEATABLE AND CONSISTENT OUTCOMES AND REDUCE THE COST OF CARE

EXPERIENCE THE STANDARD SLEEVE PORTFOLIO OF SURGICAL SOLUTIONS

REQUEST TRAINING
REQUEST TRAINING*

Please fill out the form below to receive training information.

*Titan SGS® is cleared for use by the U.S. Food and Drug Administration (FDA). It is currently only available for purchase and use in the United States of America (USA).

NEW Study

Titan SGS™ Stapler linked to improved 1 year post-op GERD outcomes in new retrospective study. 

Ying L, Rutledge R, Butensky S, Farinas Lugo D, Morton JM, Ringold F. Does stapling platform influence robotic sleeve gastrectomy postoperative outcomes? Obes Surg. 2025;35(4). doi:10.1007/s11695-025-07855-z

 

Dr. Morton and Dr. Ringold, two of the authors of the study, are paid consultants of Teleflex Incorporated.

View the Study

New propensity matched retrospective study reports perioperative outcomes of the Titan SGSTM Stapler.

View the Study

Thank you for joining the community of bariatric surgeons interested in the Titan SGS®.

We'll connect with you soon.